- Report
- December 2023
- 100 Pages
Africa
From €1895EUR$2,000USD£1,599GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1421EUR$1,500USD£1,200GBP
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Poland
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Germany
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
India
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
United States
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Vietnam
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 180 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- July 2023
- 80 Pages
United Kingdom
From €1421EUR$1,500USD£1,200GBP
From €1421EUR$1,500USD£1,200GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more